Clarus Therapeutics, Inc.
- Country
- ๐บ๐ธUnited States
- Ownership
- Public, Subsidiary
- Established
- 2003-01-01
- Employees
- 11
- Market Cap
- -
Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes
- First Posted Date
- 2019-06-04
- Last Posted Date
- 2019-07-09
- Lead Sponsor
- Clarus Therapeutics, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT03973840
- Locations
- ๐บ๐ธ
Clarus Therapeutics, Inc, Northbrook, Illinois, United States
The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate
- First Posted Date
- 2016-10-03
- Last Posted Date
- 2018-05-17
- Lead Sponsor
- Clarus Therapeutics, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT02921386
- Locations
- ๐บ๐ธ
Harbor-UCLA Medical Center, Torrance, California, United States
๐บ๐ธOrlando Clinical Research Center, Orlando, Florida, United States
A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
- Conditions
- Interventions
- First Posted Date
- 2016-03-29
- Last Posted Date
- 2018-02-23
- Lead Sponsor
- Clarus Therapeutics, Inc.
- Target Recruit Count
- 222
- Registration Number
- NCT02722278
- Locations
- ๐บ๐ธ
Multiple Sites in the United States, Northbrook, Illinois, United States
Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
- Conditions
- Interventions
- First Posted Date
- 2016-03-03
- Last Posted Date
- 2018-11-01
- Lead Sponsor
- Clarus Therapeutics, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT02697188
- Locations
- ๐บ๐ธ
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles, California, United States
๐บ๐ธdgd Research, Inc, San Antonio, Texas, United States
Phlebotomy Study of Testosterone Undecanoate
- First Posted Date
- 2016-02-01
- Last Posted Date
- 2018-03-09
- Lead Sponsor
- Clarus Therapeutics, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT02670343
- Locations
- ๐บ๐ธ
Los Angeles Biomedical Research Institute, Torrance, California, United States
Safety and Efficacy Trial of Testosterone Undecanoate
- First Posted Date
- 2013-01-10
- Last Posted Date
- 2017-12-12
- Lead Sponsor
- Clarus Therapeutics, Inc.
- Target Recruit Count
- 144
- Registration Number
- NCT01765179
- Locations
- ๐บ๐ธ
Medical Affliated Research Center, Inc., Huntsville, Alabama, United States
๐บ๐ธSC Clinical Research, Inc., Garden Grove, California, United States
๐บ๐ธSouth ORange County Endocrinology, Laguna Hill, California, United States
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
- Conditions
- Interventions
- First Posted Date
- 2012-10-03
- Last Posted Date
- 2021-06-28
- Lead Sponsor
- Clarus Therapeutics, Inc.
- Target Recruit Count
- 182
- Registration Number
- NCT01699178
- Locations
- ๐บ๐ธ
Providence Clinical Research, Burbank, California, United States
๐บ๐ธAlabama Clinical Therapeutics, Inc., Birmingham, Alabama, United States
๐บ๐ธAlabama Clinical Therapeutics, Calera, Alabama, United States
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
- Conditions
- Interventions
- First Posted Date
- 2011-07-27
- Last Posted Date
- 2018-08-14
- Lead Sponsor
- Clarus Therapeutics, Inc.
- Target Recruit Count
- 325
- Registration Number
- NCT01403116
- Locations
- ๐บ๐ธ
Bruce R. Gilbert, MD, PhD, Great Neck, New York, United States
๐บ๐ธProvidence Clinical Research, Burbank, California, United States
๐บ๐ธJohns Hopkins University, Baltimore, Maryland, United States
Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation
- Conditions
- Interventions
- First Posted Date
- 2009-06-19
- Last Posted Date
- 2020-12-02
- Lead Sponsor
- Clarus Therapeutics, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT00924612
- Locations
- ๐บ๐ธ
LABiomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States
๐จ๐ฆAnapharm, Inc., Quebec City, Quebec, Canada
Pharmacokinetic Study to Determine Time to Steady-state
- Conditions
- Interventions
- First Posted Date
- 2009-06-02
- Last Posted Date
- 2020-12-11
- Lead Sponsor
- Clarus Therapeutics, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT00911586
- Locations
- ๐บ๐ธ
Alabama Clinical Therapeutics, Birmingham, Alabama, United States